SCHEMBL4438934

SCHEMBL4438934

C1CCC2(C1)CCO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16877413 0.96 KCNH2 (0.31)
SCHEMBL16877349 0.96 KCNH2 (0.31)
SCHEMBL16877509 0.96
SCHEMBL14370807 0.92
SCHEMBL126707 0.89
SCHEMBL3658994 0.89 KCNH2 (0.38)
SCHEMBL15568524 0.87
SCHEMBL465080 0.86 KCNH2 (0.37)
SCHEMBL21844963 0.86 KCNH2 (0.37)
SCHEMBL16878094 0.86 KCNH2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044486-A1 JAK2 INHIBITOR COMPOUNDS AJAX THERAPEUTICS, INC. (US) 2024-02-29 WO claimed
CN-118666846-A Benzocarbonylindole derivative and application thereof 山东新时代药业有限公司 2024-09-20 CN disclosed
US-20240101531-A1 PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS XENON PHARMACEUTICALS INC. (CA) 2024-03-28 US disclosed
WO-2024044486-A1 JAK2 INHIBITOR COMPOUNDS AJAX THERAPEUTICS, INC. (US) 2024-02-29 WO disclosed
US-11777142-B2 Gelable system containing ether compounds, preparation method therefor and use thereof BEIJING NORMAL UNIVERSITY (CN) 2023-10-03 US disclosed
US-11777142-B2 Gelable system containing ether compounds, preparation method therefor and use thereof BEIJING NORMAL UNIVERSITY (CN) 2023-10-03 US disclosed
US-11545696-B2 Gelable system and uses thereof in lithium-air batteries, organic supercapacitors or capacitor batteries BEIJING NORMAL UNIVERSITY (CN) 2023-01-03 US disclosed
EP-3740487-A1 BENZAMIDE COMPOUNDS Recurium IP Holdings, LLC (US) 2020-11-25 EP disclosed
EP-3737681-A1 BENZAMIDE COMPOUNDS Recurium IP Holdings, LLC (US) 2020-11-18 EP disclosed
EP-3737672-A1 BENZAMIDE COMPOUNDS Recurium IP Holdings, LLC (US) 2020-11-18 EP disclosed
US-20200099090-A1 FLEXIBLE ALL-SOLID-STATE LITHIUM-ION SECONDARY BATTERY AND PREPARATION METHOD THEREOF BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 US disclosed
US-20200099097-A1 GELABLE SYSTEM AND USES THEREOF IN LITHIUM-AIR BATTERIES, ORGANIC SUPERCAPACITORS OR CAPACITOR BATTERIES BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 US disclosed
US-20200099096-A1 Gelable System Containing Ether Compounds, Preparation Method Therefor and Use Thereof BEIJING NORMAL UNIVERSITY (CN) 2020-03-26 US disclosed
US-20170247366-A1 SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2017-08-31 US disclosed
US-20160326157-A1 MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-11-10 US disclosed
WO-2015200682-A1 SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS DS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS VANDERBILT UNIVERSITY (US) 2015-12-30 WO disclosed
WO-2015103583-A1 MONOBACTAMS AND METHODS OF THEIR SYNTHESIS AND USE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-07-09 WO disclosed
EP-2121656-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE Pfizer Products Inc. (US) 2009-11-25 EP disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO disclosed